N2Growth Blog
OCTOBER 23, 2023
Understanding the Unique Challenges in Recruiting for Biotech and Life Sciences The recruitment process in the biotech and life sciences industry comes with its own set of unique challenges. One of the primary obstacles is the need for more highly skilled and qualified talent.
Crunchbase News
DECEMBER 12, 2024
Earlier this week, life sciences venture firm Dimension Capital announced it had raised a new $500 million second fund just two years after its first to hunt for startups that are using artificial intelligence to develop new medicines. Venture funding to AI-related biotech and healthcare startups hit only $4.8
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Crunchbase News
JUNE 21, 2024
Biotech/healthcare and cybersecurity dominated the run of big rounds this week, with a few AI startups also seeing good-sized checks. Marea Therapeutics , $190M, biotech: This big biotech round is actually the combination of two rounds. The top five raises this week came from sectors that have seen good heat recently.
TechCrunch
JUNE 6, 2022
Insilico Medicine, a Hong Kong-based company that has been using artificial intelligence to discover new drugs since 2014, has completed a fresh round of funding. This presents an opportunity for Insilico Medicine to emerge as a winner during the biotech spring.”
Crunchbase News
NOVEMBER 1, 2024
startups raised half a billion dollars apiece, and another eight raised $100 million or more, with industries from cybersecurity to biotech to AI represented. Sierra , $175M, artificial intelligence: If you want to have your company’s valuation skyrocket in the blink of an eye, start an AI startup. billion valuation.
TechCrunch
MARCH 17, 2023
Best practices for leveraging artificial intelligence and machine learning in 2023 Zero-based budgeting: A proven framework for extending runway Image Credits: Getty Images It’s critical to make every dollar count in this environment, but pulling back too much in the wrong places can reduce momentum across your entire organization. “The
TechCrunch
MAY 31, 2022
The appetite for genomic data continues to rise in the field of biotech and pharmaceutical research, but cost is still a factor — even sequencing a full genome now costs as little as $1,000. I asked Almogy what he felt were the areas of the biotech and medical industry that will benefit most from this new capability.
Expert insights. Personalized for you.
178 
Let's personalize your content